title: Expanded access drug profile: raltegravir (RAL, MK-0518).
authors.forename: Amanda R
authors.initials: AR
authors.lastname: Colquitt
authors.forename: Paul A
authors.initials: PA
authors.lastname: Pham
mesh_terms: D004347:Drug Interactions; D019428:HIV Integrase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009930:Organic Chemicals / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011760:Pyrrolidinones; D000068898:Raltegravir Potassium; D016032:Randomized Controlled Trials as Topic
chemical_list: D019428:HIV Integrase Inhibitors; D009930:Organic Chemicals; D011760:Pyrrolidinones; D000068898:Raltegravir Potassium